OPKO Health Total Liabilities 2011-2025 | OPK

OPKO Health total liabilities from 2011 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2024 $835
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2025-09-30 $690
2025-06-30 $676
2025-03-31 $817
2024-12-31 $835
2024-09-30 $853
2024-06-30 $585
2024-03-31 $721
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.029B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $215.059B 25.55
Intuitive Surgical (ISRG) United States $200.747B 78.54
IDEXX Laboratories (IDXX) United States $56.571B 56.18
Edwards Lifesciences (EW) United States $48.391B 32.45
Alcon (ALC) Switzerland $36.485B 24.49
IQVIA Holdings (IQV) United States $35.841B 19.99
Mettler-Toledo (MTD) United States $29.649B 34.40
STERIS (STE) Ireland $25.888B 26.72
Waters (WAT) United States $22.128B 29.27
DexCom (DXCM) United States $21.451B 29.57
Hologic (HOLX) United States $16.481B 17.35
SONOVA HOLDING (SONVY) Switzerland $15.721B 0.00
Globus Medical (GMED) United States $11.330B 23.57
Penumbra (PEN) United States $10.425B 73.33
Masimo (MASI) United States $7.690B 24.64
Sysmex ADR (SSMXY) Japan $6.698B 21.28
Teleflex (TFX) United States $4.835B 7.70
Glaukos (GKOS) United States $4.816B 0.00
TransMedics (TMDX) United States $4.073B 48.25
Veracyte (VCYT) United States $3.296B 37.57
Alphatec Holdings (ATEC) United States $2.941B 0.00
LivaNova (LIVN) United Kingdom $2.755B 14.88
Integer Holdings (ITGR) United States $2.392B 11.23
Artivion (AORT) United States $2.117B 97.54
Nihon Kohden (NHNKY) Japan $2.067B 24.67
PROCEPT BioRobotics (PRCT) United States $1.784B 0.00
Elekta AB (EKTAY) Sweden $1.686B 16.34
Beta Bionics (BBNX) United States $1.158B 0.00
Tandem Diabetes Care (TNDM) United States $1.099B 0.00
AxoGen (AXGN) United States $1.087B 0.00
IRadimed (IRMD) United States $1.073B 51.11
Pulse Biosciences (PLSE) United States $1.048B 0.00
Integra LifeSciences Holdings (IART) United States $0.938B 5.08
SiBone (SIBN) United States $0.680B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.591B 0.00
Tactile Systems Technology (TCMD) United States $0.555B 32.29
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.521B 10.40
AngioDynamics (ANGO) United States $0.495B 0.00
ClearPoint Neuro (CLPT) United States $0.449B 0.00
NeuroPace (NPCE) United States $0.437B 0.00
OrthoPediatrics (KIDS) United States $0.427B 0.00
Mesa Laboratories (MLAB) United States $0.418B 11.59
Semler Scientific (SMLR) United States $0.418B 3.28
RxSight (RXST) United States $0.385B 0.00
Alpha Tau Medical (DRTS) Israel $0.327B 0.00
Delcath Systems (DCTH) United States $0.305B 50.82
Sight Sciences (SGHT) United States $0.305B 0.00
Spectral Diagnostics (EDTXF) Canada $0.294B 0.00
Treace Medical Concepts (TMCI) United States $0.282B 0.00
908 Devices (MASS) United States $0.265B 0.00
CVRx (CVRX) United States $0.255B 0.00
Inogen (INGN) United States $0.189B 0.00
Neuronetics (STIM) United States $0.156B 0.00
Lucid Diagnostics (LUCD) United States $0.144B 0.00
Anteris Technologies Global (AVR) Australia $0.144B 0.00
Microbot Medical (MBOT) United States $0.138B 0.00
Rapid Micro Biosystems (RPID) United States $0.137B 0.00
Accuray (ARAY) United States $0.133B 0.00
LENSAR (LNSR) United States $0.127B 0.00
Atossa Genetics (ATOS) United States $0.106B 0.00
Zomedica (ZOMDF) United States $0.094B 0.00
Hyperfine (HYPR) United States $0.084B 0.00
QT Imaging Holdings (QTIH) United States $0.077B 0.00
EDAP TMS S.A (EDAP) France $0.076B 0.00
InspireMD (NSPR) United States $0.076B 0.00
Sensus Healthcare (SRTS) United States $0.069B 0.00
Spectral AI (MDAI) United States $0.060B 0.00
Positron (POSC) United States $0.051B 0.00
Baird Medical Investment Holdings (BDMD) $0.038B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
Vicarious Surgical (RBOT) United States $0.026B 0.00
NexGel (NXGL) United States $0.020B 0.00
Envoy Medical (COCH) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.014B 0.00
EnVVeno Medical (NVNO) United States $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.012B 0.00
Tenon Medical (TNON) United States $0.010B 0.00
Check-Cap (CHEK) Israel $0.010B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Solana (HSDT) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Nanovibronix (NAOV) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
WORK Medical Technology Group (WOK) China $0.002B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 11.54
Longview Acquisition II (LGV) United States $0.000B 0.00